Companies Mckesson Corp
Mckesson (MCK): executive pay, fiscal 2026
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Mckesson Corp’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $18,997,543FY2024
- $20,161,714FY2025
- $24,213,044FY2026
CEO total pay was $24,213,044 in fiscal 2026, up from $20,161,714 in fiscal 2025.
FY2026: salary $1,591,667 · bonus $0 · stock awards $17,201,202 · option awards $0
Executives and directors
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Brian Tyler | $1,591,667 | $0 | $17,201,202 | $0 | $4,456,668 | $0 | $963,507 | $24,213,044 |
| Chief Executive Officer | ||||||||
| Britt Vitalone | 1,064,333 | 0 | 5,600,332 | 0 | 1,862,583 | 0 | 209,815 | 8,737,063 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Michele Lau | 766,583 | 0 | 3,651,388 | 0 | 1,073,216 | 0 | 104,870 | 5,596,057 |
| Executive Vice President and Chief Legal Officer | ||||||||
| LeAnn Smith | 693,833 | 0 | 2,500,580 | 0 | 971,366 | 0 | 87,930 | 4,253,709 |
| Executive Vice President and Chief Human Resources Officer | ||||||||
| Thomas Rodgers | 647,450 | 0 | 1,750,698 | 0 | 906,430 | 0 | 81,973 | 3,386,551 |
| Executive Vice President and Chief Strategy and Business Development Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2026 total | FY2025 total | FY2024 total | Δ FY2025→2026 |
|---|---|---|---|---|
| Brian Tyler | $24,213,044 | $20,161,714 | $18,997,543 | ↑ +4,051,330 |
| Britt Vitalone | 8,737,063 | 7,682,181 | 6,782,661 | ↑ +1,054,882 |
| Michele Lau | 5,596,057 | 5,226,705 | 8,806,254 | ↑ +369,352 |
| LeAnn Smith | 4,253,709 | 3,717,899 | 3,541,115 | ↑ +535,810 |
| Thomas Rodgers | 3,386,551 | 3,213,307 | 3,178,976 | ↑ +173,244 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
McKesson's executive compensation program is predominantly variable and performance-based, designed to align executive interests with long-term shareholder value creation. The program emphasizes a mix of operational and market-based metrics, with a focus on Adjusted EPS, Adjusted Operating Profit, Free Cash Flow, and Relative Total Shareholder Return, while incorporating non-financial priority areas as a downward-only modifier.
| CEO STI target (% of salary) | 200% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Korn Ferry |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2026
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Britt Vitalone | RSU | 2025-05-20 | — | — | 3,115 | — | $2,240,277 |
| Thomas Rodgers | RSU | 2025-05-20 | — | — | 974 | — | 700,491 |
| Thomas Rodgers | PSU | 2025-05-20 | 554 | 1,384 | — | 3,322 | 1,050,207 |
| Brian Tyler | RSU | 2025-05-20 | — | — | 9,567 | — | 6,880,491 |
| Michele Lau | RSU | 2025-05-20 | — | — | 2,031 | — | 1,460,675 |
| Britt Vitalone | PSU | 2025-05-20 | 1,771 | 4,428 | — | 10,627 | 3,360,055 |
| LeAnn Smith | PSU | 2025-05-20 | 791 | 1,977 | — | 4,745 | 1,500,187 |
| Brian Tyler | PSU | 2025-05-20 | 5,440 | 13,601 | — | 32,642 | 10,320,711 |
| LeAnn Smith | RSU | 2025-05-20 | — | — | 1,391 | — | 1,000,393 |
| Michele Lau | PSU | 2025-05-20 | 1,155 | 2,887 | — | 6,929 | 2,190,713 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Britt Vitalone | $2,240,277 | $3,360,055 | $0 | 60.0% |
| Thomas Rodgers | 700,491 | 1,050,207 | 0 | 60.0% |
| Brian Tyler | 6,880,491 | 10,320,711 | 0 | 60.0% |
| Michele Lau | 1,460,675 | 2,190,713 | 0 | 60.0% |
| LeAnn Smith | 1,000,393 | 1,500,187 | 0 | 60.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2026
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Thomas Rodgers | RSU | 2,414 | — | $2,088,979 |
| LeAnn Smith | RSU | 3,133 | — | 2,711,173 |
| Michele Lau | RSU | 4,238 | — | 3,667,396 |
| Britt Vitalone | RSU | 7,005 | — | 6,061,847 |
| Thomas Rodgers | PSU | 10,512 | — | 9,096,664 |
| LeAnn Smith | PSU | 13,368 | — | 11,568,132 |
| Michele Lau | PSU | 17,511 | — | 15,153,319 |
| Brian Tyler | RSU | 21,146 | — | 18,298,903 |
| Britt Vitalone | PSU | 29,818 | — | 25,803,304 |
| Brian Tyler | PSU | 90,115 | — | 77,981,916 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Donald R. KnaussIndependent · Board Chair · Compensation and Talent (Chair) · Not standing for re-election | $260,000 | $335,297 | $0 | — | $0 | $595,297 |
| Dominic J. CarusoIndependent · Lead Independent Director · Compensation and Talent · Governance and Sustainability · Audit (Chair) | 145,000 | 215,191 | 0 | — | 0 | 360,191 |
| Kevin M. OzanIndependent · Audit (Chair) | 140,000 | 215,191 | 0 | — | 0 | 355,191 |
| Bradley E. LermanIndependent · Compensation and Talent (Chair) | 140,000 | 215,191 | 0 | — | 0 | 355,191 |
| Maria N. MartinezIndependent · Finance | 140,000 | 215,191 | 0 | — | 0 | 355,191 |
| Lynne M. DoughtieIndependent · Audit · Finance · Newly elected | 139,000 | 215,191 | 0 | — | 0 | 354,191 |
| Julie L. Gerberding, M.D., M.P.HIndependent · Compensation and Talent · Newly elected | 139,000 | 215,191 | 0 | — | 0 | 354,191 |
| James H. HintonIndependent · Audit | 120,000 | 215,191 | 0 | — | 0 | 335,191 |
| W. Roy DunbarIndependent · Compliance (Chair) · Governance and Sustainability | 120,000 | 215,191 | 0 | — | 0 | 335,191 |
| Deborah Dunsire, M.DIndependent · Audit · Finance | 120,000 | 215,191 | 0 | — | 0 | 335,191 |
| Kathleen Wilson-ThompsonIndependent · Compensation and Talent | 120,000 | 215,191 | 0 | — | 0 | 335,191 |
| Richard H. Carmona, M.DIndependent · Not standing for re-election · Departed during FY | 40,109 | 215,191 | 0 | — | 0 | 255,300 |
Board fee structure and ownership guideline
| Annual cash retainer | $115,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 20,000 |
| Stock ownership guideline | 6x annual cash retainer ($690,000) |
Total cost of the board
| Component | FY2026 |
|---|---|
| Cash retainers and fees | $1,623,109 |
| Equity awards (grant-date value) | $2,702,398 |
| All other compensation | $0 |
| Total cost of the board | $4,325,507 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Mckesson as a peer
Companies that benchmark against MCK
12 companies name MCK as a compensation peer
The list of companies that name MCK as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2026
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Peer reciprocity
The companies Mckesson Corp names as compensation peers that name it back in their own disclosed peer groups.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | UnitedHealth Group | 2025 | Stephen Hemsley | $596,154 | $0 | $60,000,024 | $0 | $60,938,062 |
| 2 | Johnson & Johnson | 2025 | Joaquin Duato | 1,600,000 | 15,028,948 | 5,927,995 | 4,298,700 | 32,758,111 |
| 3 | Walmart | 2026 | Doug McMillon | 1,500,000 | 21,051,605 | 0 | 4,032,000 | 29,240,930 |
| 4 | Pfizer | 2025 | Albert Bourla | 1,800,000 | 9,442,705 | 8,998,141 | 5,400,000 | 27,585,301 |
| 5 | FedEx | 2026 | Rajesh Subramaniam | 1,550,000 | 6,731,364 | 3,715,062 | 10,593,500 | 27,554,018 |
| 6 | HCA Healthcare | 2025 | Samuel Hazen | 1,577,815 | 8,474,543 | 8,514,090 | 5,416,732 | 26,456,606 |
| 7 | Mckesson Corp | 2026 | Brian Tyler | 1,591,667 | 17,201,202 | 0 | 4,456,668 | 24,213,044 |
| 8 | Abbott Laboratories | 2025 | Robert Ford | 1,500,000 | 8,787,378 | 8,788,430 | 1,968,750 | 24,198,660 |
| 9 | United Parcel Service | 2025 | Carol Tomé | 1,509,713 | 17,550,546 | 1,358,754 | 2,264,569 | 22,878,788 |
| 10 | The Cigna Group | 2025 | David Cordani | 1,600,000 | 13,929,161 | 3,400,019 | 3,200,000 | 22,866,134 |
| 11 | Elevance Health | 2025 | Gail Boudreaux | 1,600,000 | 13,440,277 | 4,199,765 | 2,768,000 | 22,582,314 |
| 12 | Cardinal Health | 2026 | Jason Hollar | 1,500,000 | 16,259,918 | 0 | 4,278,750 | 22,574,349 |
| 13 | CVS Health | 2025 | J. David Joyner | 1,500,000 | 14,499,931 | 0 | 4,695,900 | 21,214,084 |
| 14 | Merck & Co. | 2025 | Robert Davis | 1,645,302 | 12,102,838 | 3,380,004 | 2,326,500 | 20,797,845 |
| 15 | Procter & Gamble | 2026 | Shailesh Jejurikar | 1,387,500 | 11,035,209 | 3,500,010 | 0 | 18,976,742 |
| 16 | Humana | 2025 | James Rechtin | 1,348,558 | 13,868,141 | 0 | 3,034,740 | 18,757,075 |
| 17 | Cencora | 2025 | Robert Mauch | 1,350,000 | 12,000,218 | 0 | 4,283,213 | 18,256,227 |
| 18 | Sysco | 2026 | Kevin Hourican | 1,435,538 | 10,391,759 | 2,579,986 | 2,905,602 | 17,899,369 |
| 19 | Viatris | 2025 | Scott Smith | 1,448,654 | 10,150,013 | 0 | 2,973,660 | 15,273,331 |
| 20 | Kroger | 2025 | Ronald L. Sargent | 3,975,806 | 10,000,077 | — | — | 14,037,608 |
| 21 | Costco | 2025 | Ron Vachris | 1,183,270 | 12,036,800 | 0 | 600,000 | 13,932,597 |
| 22 | Accendra Health, Inc. (formerly Owens & Minor, Inc.) | 2025 | Edward Pesicka | 1,150,000 | 9,560,140 | — | 345,000 | 11,157,809 |
| 23 | Target | 2025 | Michael Fiddelke | 1,065,385 | 7,853,253 | 0 | 300,882 | 9,598,071 |
| — | Sanofi | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Mckesson Corp | 140% | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) relative to comparator group | Korn Ferry |
| Abbott Laboratories | 75.0% | Options 50 · PSU 50 | No | Meridian Compensation Partners, LLC |
| Accendra Health, Inc. (formerly Owens & Minor, Inc.) | 20% | RSU 50 · PSU 50 | not disclosed | Frederic W. Cook & Co., Inc. (FW Cook) |
| Cardinal Health | not disclosed | PSU 60 · RSU 40 | Yes — Relative TSR modifier | Korn Ferry |
| Cencora | 181.3% | PSU 60 · RSU 40 | Yes — Relative TSR | Pearl Meyer & Partners |
| Costco | 120% | RSU 100 | No | None used (Committee has authority to engage consultants but did not use any) |
| CVS Health | 156.5% | PSU 60 · RSU 20 · Options 20 | Yes — rTSR Modifier | Korn Ferry |
| Elevance Health | 86.5% | PSU 52 · RSU 24 · Options 24 | No | Willis Towers Watson (WTW) |
| FedEx | 112.5% | not disclosed | Yes — Relative TSR (FY24-FY26 LTI Cash Plan) | Meridian Compensation Partners, LLC |
| HCA Healthcare | 195.78% | SAR 50 · PSU 50 | No | Semler Brossy |
| Humana | 112% | PSU 60 · RSU 40 | Yes — Relative TSR | Farient Advisors, LLC |
| Johnson & Johnson | not disclosed | not disclosed | Yes — Relative TSR | Semler Brossy Consulting Group |
| Kroger | 93.84% | not disclosed | Yes — Value creation (iTSR) | Korn Ferry; Meridian Compensation Partners, LLC |
| Merck & Co. | 94% | PSU 60 · RSU 20 · Options 20 | Yes — Relative Total Shareholder Return (R-TSR) | FW Cook |
| Pfizer | 150% | PSU 50 · MSU 50 | Yes — relative TSR as compared to the NYSE Arca Pharmaceutical Index (DRG Index or DRG) | Meridian Compensation Partners, LLC |
| Procter & Gamble | not disclosed | PSU 50 · RSU 25 · Option 25 | Yes — Relative TSR Multiplier | Meridian Compensation Partners, LLC |
| Sanofi | not disclosed | not disclosed | not disclosed | not disclosed |
| Sysco | 115.66% | PSU 50 · RSU 30 · Option 20 | No | Semler Brossy |
| Target | not disclosed | PSU 60 · PBRSU 40 | No | Semler Brossy |
| The Cigna Group | 100% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| United Parcel Service | 75% | PSU 93 · Options 7 | Yes — Relative Total Shareowner Return (RTSR) | FW Cook |
| UnitedHealth Group | not disclosed | PSU 50 · Options 25 · RSU 25 | No | Pay Governance |
| Viatris | 136.72% | PSU 65 · RSU 35 | No | Meridian Compensation Partners, LLC |
| Walmart | 112% | not disclosed | No | Farient Advisors LLC |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-07-22 | 86,580,776 | 7,732,776 | 387,199 | 91.43% | Passed |
| 2025 | 2025-07-30 | 91,831,997 | 7,955,440 | 769,779 | 91.32% | Passed |
| 2025 | 2025-07-30 | 91,831,997 | 7,955,440 | 769,779 | 91.32% | Passed |
| 2023 | 2023-07-21 | 96,483,473 | 11,840,048 | 236,251 | 88.88% | Passed |
| 2022 | 2022-07-22 | 104,716,045 | 11,952,227 | 535,693 | 89.76% | Passed |
| 2021 | 2021-07-23 | 111,683,244 | 12,582,546 | 475,258 | 89.87% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-07-22 | 91.43%a |
| 2025 | 2025-07-30 | 91.32%b |
| 2025 | 2025-07-30 | 91.32%c |
a. Approved under the standard stated in the filing — “Shares represented by abstentions will have the effect of a vote against this proposal.”.
b. Approved under the standard stated in the filing — “Shares represented by abstentions will have the effect of a vote against this proposal.”.
c. Approved under the standard stated in the filing — “Shares represented by abstentions will have the effect of a vote against this proposal.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 357 : 1 |
|---|---|
| CEO total compensation | $24,213,044 |
| Median employee compensation | $67,803 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2026 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Brian Tyler | Director | 2026-06-17 | D | 8,463 | $775 | $6,559,925 | Common | Form 4 ↗ |
| Brian Tyler | Director | 2026-07-07 | D | 8,463 | 794 | 6,715,898 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-07-22 | — | 1,939 | — | — | 7 insiders, 7 accrual rows | ||
| Dominic J. Caruso | Director | 2026-07-22 | A | 277 | 814 | 225,489 | Common | Form 4 ↗ |
| Maria N. Martinez | Director | 2026-07-22 | A | 277 | 814 | 225,489 | Common | Form 4 ↗ |
| Kathleen Wilson-Thompson | Director | 2026-07-22 | A | 277 | 814 | 225,489 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-07 | — | 368 | — | — | 1 insider, 1 accrual row | ||
| Bradley E. Lerman | Director | 2026-08-10 | D | 301 | 892 | 268,590 | Common | Form 4 ↗ |
| Napoleon B. Rutledge JR | SVP, Controller & CAO | 2026-09-08 | D | 111 | 891 | 98,951 | Common | Form 4 ↗ |
| Francisco Fraga | EVP, CIO and CTO | 2026-10-15 | D | 800.49 | 996 | 797,129 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
View all 16 transactions
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Brian Tyler | Director | 2026-06-17 | D | 8,463 | $775 | $6,559,925 | Common | Form 4 ↗ |
| Brian Tyler | Director | 2026-07-07 | D | 8,463 | 794 | 6,715,898 | Common | Form 4 ↗ |
| Julie L. Gerberding | Director | 2026-07-22 | A | 277 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dominic J. Caruso | Director | 2026-07-22 | A | 277 | 814 | 225,489 | Common | Form 4 ↗ |
| W. Roy Dunbar | Director | 2026-07-22 | A | 277 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lynne M. Doughtie | Director | 2026-07-22 | A | 277 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| James H. Hinton | Director | 2026-07-22 | A | 277 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Dunsire | Director | 2026-07-22 | A | 277 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kevin M. Ozan | Director | 2026-07-22 | A | 277 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Maria N. Martinez | Director | 2026-07-22 | A | 277 | 814 | 225,489 | Common | Form 4 ↗ |
| Kathleen Wilson-Thompson | Director | 2026-07-22 | A | 277 | 814 | 225,489 | Common | Form 4 ↗ |
| Bradley E. Lerman | Director | 2026-07-22 | A | 277 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ramesh (NMN) Srinivasan | EVP and Chief Strategy Officer | 2026-08-07 | A | 368 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bradley E. Lerman | Director | 2026-08-10 | D | 301 | 892 | 268,590 | Common | Form 4 ↗ |
| Napoleon B. Rutledge JR | SVP, Controller & CAO | 2026-09-08 | D | 111 | 891 | 98,951 | Common | Form 4 ↗ |
| Francisco Fraga | EVP, CIO and CTO | 2026-10-15 | D | 800.49 | 996 | 797,129 | Common | Form 4 ↗ |
Sources (81 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Brian Tyler. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 24,213,044. View filing ↗
- Section 01, Britt Vitalone. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 8,737,063. View filing ↗
- Section 01, Michele Lau. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 5,596,057. View filing ↗
- Section 01, LeAnn Smith. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 4,253,709. View filing ↗
- Section 01, Thomas Rodgers. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 3,386,551. View filing ↗
- Section 03, Britt Vitalone RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Thomas Rodgers RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Thomas Rodgers PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Tyler RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Michele Lau RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Britt Vitalone PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, LeAnn Smith PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Tyler PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, LeAnn Smith RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Michele Lau PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-06-12. Section “CEO Pay Ratio”. As printed: 357 : 1. View filing ↗
- Section 08, Donald R. Knauss. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 595,297. View filing ↗
- Section 08, Dominic J. Caruso. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 360,191. View filing ↗
- Section 08, Kevin M. Ozan. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 355,191. View filing ↗
- Section 08, Bradley E. Lerman. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 355,191. View filing ↗
- Section 08, Maria N. Martinez. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 355,191. View filing ↗
- Section 08, Lynne M. Doughtie. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 354,191. View filing ↗
- Section 08, Julie L. Gerberding, M.D., M.P.H. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 354,191. View filing ↗
- Section 08, James H. Hinton. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 335,191. View filing ↗
- Section 08, W. Roy Dunbar. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 335,191. View filing ↗
- Section 08, Deborah Dunsire, M.D. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 335,191. View filing ↗
- Section 08, Kathleen Wilson-Thompson. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 335,191. View filing ↗
- Section 08, Richard H. Carmona, M.D. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 255,300. View filing ↗
- Section 02, Brian Tyler 2026-06-17. Form 4, filed 2026-06-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brian Tyler 2026-07-07. Form 4, filed 2026-07-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Julie L. Gerberding 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dominic J. Caruso 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, W. Roy Dunbar 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lynne M. Doughtie 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, James H. Hinton 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Dunsire 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kevin M. Ozan 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Maria N. Martinez 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kathleen Wilson-Thompson 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradley E. Lerman 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ramesh (NMN) Srinivasan 2026-08-07. Form 4, filed 2026-08-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradley E. Lerman 2026-08-10. Form 4, filed 2026-08-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Napoleon B. Rutledge JR 2026-09-08. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Francisco Fraga 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-07-24. Item 5.07 · say-on-pay result. As reported: 91.43% (votes for as printed: 86,580,776). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-08-01. Item 5.07 · say-on-pay result. As reported: 91.32% (votes for as printed: 91,831,997). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-08-01. Item 5.07 · say-on-pay result. As reported: 91.32% (votes for as printed: 91,831,997). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,623,109 + equity 2,702,398 + all other 0 = 4,325,507, summed across the director compensation table rows.
- UnitedHealth Group, Section 10b CEO total. DEF 14A, filed 2026-04-21. CEO total compensation as printed in UnitedHealth Group's own proxy. As printed: 60,938,062. View filing ↗
- Johnson & Johnson, Section 10b CEO total. DEF 14A, filed 2026-03-11. CEO total compensation as printed in Johnson & Johnson's own proxy. As printed: 32,758,111. View filing ↗
- Walmart, Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Walmart's own proxy. As printed: 29,240,930. View filing ↗
- Pfizer, Section 10b CEO total. DEF 14A, filed 2026-03-12. CEO total compensation as printed in Pfizer's own proxy. As printed: 27,585,301. View filing ↗
- FedEx, Section 10b CEO total. DEF 14A, filed 2026-08-17. CEO total compensation as printed in FedEx's own proxy. As printed: 27,554,018. View filing ↗
- HCA Healthcare, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in HCA Healthcare's own proxy. As printed: 26,456,606. View filing ↗
- Mckesson Corp (subject), Section 10b CEO total. DEF 14A, filed 2026-06-12. CEO total compensation as printed in Mckesson Corp's own proxy. As printed: 24,213,044. View filing ↗
- Abbott Laboratories, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in Abbott Laboratories's own proxy. As printed: 24,198,660. View filing ↗
- United Parcel Service, Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in United Parcel Service's own proxy. As printed: 22,878,788. View filing ↗
- The Cigna Group, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in The Cigna Group's own proxy. As printed: 22,866,134. View filing ↗
- Elevance Health, Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Elevance Health's own proxy. As printed: 22,582,314. View filing ↗
- Cardinal Health, Section 10b CEO total. DEF 14A, filed 2026-09-21. CEO total compensation as printed in Cardinal Health's own proxy. As printed: 22,574,349. View filing ↗
- CVS Health, Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in CVS Health's own proxy. As printed: 21,214,084. View filing ↗
- Merck & Co., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Merck & Co.'s own proxy. As printed: 20,797,845. View filing ↗
- Procter & Gamble, Section 10b CEO total. DEF 14A, filed 2026-08-28. CEO total compensation as printed in Procter & Gamble's own proxy. As printed: 18,976,742. View filing ↗
- Humana, Section 10b CEO total. DEFR 14A, filed 2026-03-06. CEO total compensation as printed in Humana's own proxy. As printed: 18,757,075. View filing ↗
- Cencora, Section 10b CEO total. DEF 14A, filed 2026-01-22. CEO total compensation as printed in Cencora's own proxy. As printed: 18,256,227. View filing ↗
- Sysco, Section 10b CEO total. DEF 14A, filed 2026-10-01. CEO total compensation as printed in Sysco's own proxy. As printed: 17,899,369. View filing ↗
- Viatris, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Viatris's own proxy. As printed: 15,273,331. View filing ↗
- Kroger, Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in Kroger's own proxy. As printed: 14,037,608. View filing ↗
- Costco, Section 10b CEO total. DEF 14A, filed 2025-12-04. CEO total compensation as printed in Costco's own proxy. As printed: 13,932,597. View filing ↗
- Accendra Health, Inc. (formerly Owens & Minor, Inc.), Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Accendra Health, Inc. (formerly Owens & Minor, Inc.)'s own proxy. As printed: 11,157,809. View filing ↗
- Target, Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Target's own proxy. As printed: 9,598,071. View filing ↗
- Section 10a, Cardinal Health reciprocity. DEF 14A. Cardinal Health names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Cencora reciprocity. DEF 14A. Cencora names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Elevance Health reciprocity. DEF 14A. Elevance Health names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, HCA Healthcare reciprocity. DEF 14A. HCA Healthcare names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Humana reciprocity. DEF 14A. Humana names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, The Cigna Group reciprocity. DEF 14A. The Cigna Group names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, UnitedHealth Group reciprocity. DEF 14A. UnitedHealth Group names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Walmart reciprocity. DEF 14A. Walmart names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗